Enfusion Stock Options
| ENFN Stock | USD 11.32 0.02 0.18% |
Enfusion's latest option contracts expiring on May 16th 2025 are carrying combined implied volatility of 1.32 with a put-to-call open interest ratio of 0.36 over 14 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on May 16th 2025. The total put volume is at 1.0.
Open Interest Against May 16th 2025 Option Contracts
2025-05-16
The chart above shows Enfusion's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Enfusion's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Enfusion's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Enfusion
Analyzing Enfusion's in-the-money options over time can help investors to take a profitable long position in Enfusion regardless of its overall volatility. This is especially true when Enfusion's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Enfusion's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Enfusion's stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Enfusion lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Enfusion's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Enfusion contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Enfusion Stock moves the wrong way.
Enfusion In The Money Call Balance
When Enfusion's strike price is surpassing the current stock price, the option contract against Enfusion stock is said to be in the money. When it comes to buying Enfusion's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Enfusion are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Enfusion Current Options Market Mood
Enfusion's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Enfusion Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Enfusion's options investors are not very successful. Enfusion's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Enfusion contract
Base on the Rule 16, the options market is currently suggesting that Enfusion will have an average daily up or down price movement of about 0.0825% per day over the life of the 2025-05-16 option contract. With Enfusion trading at USD 11.32, that is roughly USD 0.009339. If you think that the market is fully incorporating Enfusion's daily price movement you should consider buying Enfusion options at the current volatility level of 1.32%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Enfusion |
Purchasing Enfusion options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Enfusion calls. Remember, the seller must deliver Enfusion stock to the call owner when a call is exercised.
Enfusion Option Chain
When Enfusion's strike price is surpassing the current stock price, the option contract against Enfusion stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Enfusion's option chain is a display of a range of information that helps investors for ways to trade options on Enfusion. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Enfusion. It also shows strike prices and maturity days for a Enfusion against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ENFN250516C00002500 | 0 | 2.5 | 6.8 - 11.1 | 8.5 | In |
Call | ENFN250516C00005000 | 1 | 5.0 | 4.3 - 8.6 | 5.31 | In |
Call | ENFN250516C00007500 | 2 | 7.5 | 2.2 - 5.5 | 1.95 | In |
Call | ENFN250516C00010000 | 62 | 10.0 | 1.25 - 3.5 | 1.45 | In |
Call | ENFN250516C00012500 | 585 | 12.5 | 0.0 - 0.25 | 0.3 | Out |
Call | ENFN250516C00015000 | 13 | 15.0 | 0.0 - 2.25 | 1.85 | Out |
Call | ENFN250516C00017500 | 15 | 17.5 | 0.0 - 2.25 | 0.01 | Out |
Put | ENFN250516P00002500 | 0 | 2.5 | 0.0 - 2.25 | 2.25 | |
Put | ENFN250516P00005000 | 0 | 5.0 | 0.0 - 0.05 | 0.05 | |
Put | ENFN250516P00007500 | 0 | 7.5 | 0.0 - 2.25 | 2.25 | |
Put | ENFN250516P00010000 | 247 | 10.0 | 0.15 - 0.5 | 0.2 | Out |
Put | ENFN250516P00012500 | 0 | 12.5 | 0.0 - 3.8 | 3.8 | In |
Put | ENFN250516P00015000 | 0 | 15.0 | 1.45 - 6.0 | 1.45 | In |
Put | ENFN250516P00017500 | 0 | 17.5 | 3.8 - 8.5 | 3.8 | In |
Enfusion Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Enfusion Total Stockholder Equity
Total Stockholder Equity |
|
Enfusion Corporate Management
| Stephen Dorton | Chief Officer | Profile | |
| Michael Berry | Chief Officer | Profile | |
| Lorelei Skillman | Chief Officer | Profile | |
| Stephen Malherbe | Managing Partner | Profile | |
| Oleg Movchan | Interim Director | Profile | |
| Matthew Campobasso | General Secretary | Profile | |
| Bronwen Bastone | Chief Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.27) | Earnings Share 0.04 | Revenue Per Share | Quarterly Revenue Growth 0.154 | Return On Assets |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.